POSC282 Development of a Value Framework to Conclude on Clinical Added Benefit in Hungary

Although the critical appraisal procedure of health technologies in Hungary traditionally focuses on cost-effectiveness, assessment clinical added benefit (CAB) should not be neglected. To standardize procedure, we propose implementing a framework, which provides uniform set criteria to determine conclusion CAB. The aim this research is illustrate internal development process within Department Health Technology Assessment. Separate working groups (WGs) carried out initial phase development. After group concluded paper draft, first pilot was by different WG. Members aforementioned two WGs reviewed draft framework. Further assessments with separate WG configurations followed identify potential misalignment. Finally, entire consisting assessors and developers consolidated In development, drafted based reviewing methodological documentation other European HTA bodies their concept We consulted relevant scientific literature enrich our preliminary findings. Furthermore, targeted review evidence submitted as part local reimbursement dossiers feasibility check. proposed framework integrates use ESMO-MCBS CAB; final version framework’s included Department’s knowledge repository. developed enables efficient formulation CAB compared current standard care context, while also helping decision-makers that are supported robust evidence. subsequent process, seek input healthcare stakeholders before routinely including all assessments.